[go: up one dir, main page]

Almaghrabi, 2013 - Google Patents

Isolation and characterisation of bacteriophages that infect capsulated Streptococcus pneumonia

Almaghrabi, 2013

View PDF
Document ID
17399106947403587329
Author
Almaghrabi M
Publication year

External Links

Snippet

S. pneumoniae (pneumococcus) is a major cause of pneumonia, sepsis, and meningitis, responsible for over 1.2 million deaths per year. Rates of antibiotic resistance are rising, with over one third of isolates in the US and parts of Europe showing a reduced susceptibility to …
Continue reading at figshare.le.ac.uk (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Bacteriophages
    • C12N2795/10011Bacteriophages dsDNA Bacteriophages
    • C12N2795/10041Use of virus, viral particle or viral elements as a vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Bacteriophages
    • C12N2795/00032Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Micro-organisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Micro-organisms or materials therefrom
    • A61K35/74Bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6888Hybridisation probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Similar Documents

Publication Publication Date Title
Jamalludeen et al. Isolation and characterization of nine bacteriophages that lyse O149 enterotoxigenic Escherichia coli
KR101761578B1 (en) Novel enteropathogenic Escherichia coli bacteriophage Esc-CHP-2 and its use for preventing proliferation of enteropathogenic Escherichia coli
CN112063594B (en) High-temperature-resistant salmonella bacteriophage RDP-SA-18056 and preparation process of microcapsules thereof
CN108699531B (en) Pasteurella multocida bacteriophage Pas-MUP-1 and application thereof in inhibiting proliferation of Pasteurella multocida
KR101261873B1 (en) Bacteriophage having bacteriocidal effect on Salmonella spp., the cause of sitotoxism
Ma et al. Isolation and identification of a bacteriophage capable of infecting Streptococcus suis type 2 strains
Rao et al. First report on genetic characterization, cell‐surface properties and pathogenicity of Lactococcus garvieae, emerging pathogen isolated from cage‐cultured cobia (Rachycentron canadum)
CN108699532B (en) Vibrio parahaemolyticus bacteriophage Vib-PAP-2 and use thereof for inhibiting proliferation of Vibrio parahaemolyticus
CN113164537B (en) Therapeutic phage
JP2024523382A (en) Bacteriophages against vancomycin-resistant enterococci
Letarov et al. Ecological basis for rational phage therapy
CN117286117A (en) Broad-spectrum salmonella phage SalmpYZU33 and application thereof
CN113583966A (en) Salmonella furciosus bacteriophage and application thereof
CN113166730B (en) Novel streptococcus suis bacteriophage STR-SUP-1 and use thereof in inhibiting streptococcus suis bacterial proliferation
KR101581654B1 (en) Method for prevention and treatment of Escherichia coli Type K99
CN112437810A (en) Novel streptococcus suis bacteriophage STR-SUP-2 and application thereof in inhibiting streptococcus suis bacterial proliferation
Tee et al. A newly isolated Pseudomonas otitidis phage, vB_PotS-PotUPM1 from tilapia in Malaysia
US20210161978A1 (en) Novel streptococcus suis bacteriophage str-sup-3, and use thereof for inhibiting proliferation of streptococcus suis strains
Almaghrabi Isolation and characterisation of bacteriophages that infect capsulated Streptococcus pneumonia
KR102673134B1 (en) Composition for inhibiting proliferation of Salmonella enteritidis comprising bacteriophage
Gichuhi Diversity of Vibrio Cholerae Bacteriophages From Lake Victoria, Coastal and Central Regions of Kenya and Assessment Of Their Potential as Bio Control Agents Against the Pathogen
CN118581050B (en) Salmonella phage vB-SenS-JZ291 and application thereof
Sabri et al. Isolation, Characterization and Genomic Analysis of a Novel Lytic Bacteriophage PAT1 Infecting Agrobacterium tumefaciens
EP2887949A1 (en) Therapeutic bacteriophages
Muscat Investigation of Rhodococcus equi bacteriophages from Australian horse breeding farms